(Q43206559)

16 November 2017

title

Protective effect of sulodexide on podocyte injury in adriamycin nephropathy rats (English)

1 reference

16 November 2017

1 reference

Shan Chen

1

1 reference

16 November 2017

Zhan Fang

2

1 reference

16 November 2017

Zhonghua Zhu

3

1 reference

16 November 2017

Anguo Deng

4

1 reference

16 November 2017

Jianshe Liu

5

1 reference

16 November 2017

Chun Zhang

6

1 reference

16 November 2017

publication date

29 December 2009

1 reference

Journal of Huazhong University of Science and Technology. Medical Sciences

16 November 2017

published in

1 reference

16 November 2017

volume

29

1 reference

16 November 2017

issue

6

1 reference

16 November 2017

page(s)

715-719

1 reference

The role of podocytes in proteinuria

16 November 2017

cites work

1 reference

12 December 2020

Upregulation of nestin, vimentin, and desmin in rat podocytes in response to injury

1 reference

12 December 2020

Diversities of podocyte molecular changes induced by different antiproteinuria drugs

1 reference

12 December 2020

The podocyte's response to injury: role in proteinuria and glomerulosclerosis

1 reference

12 December 2020

Oral sulodexide reduces albuminuria in microalbuminuric and macroalbuminuric type 1 and type 2 diabetic patients: the Di.N.A.S. randomized trial

1 reference

12 December 2020

Triptolide protects podocytes from puromycin aminonucleoside induced injury in vivo and in vitro

1 reference

12 December 2020

New approaches to the treatment of dense deposit disease

1 reference

12 December 2020

Emerging therapies for chronic kidney disease: what is their role?

1 reference

12 December 2020

Heparanase in glomerular diseases

1 reference

12 December 2020

Anti-proteinuric effects of glycosaminoglycan-based drugs

1 reference

12 December 2020

Glycosaminoglycan therapy prevents TGF-beta1 overexpression and pathologic changes in renal tissue of long-term diabetic rats.

1 reference

12 December 2020

Downregulation of CD2-associated protein impaired the physiological functions of podocytes

1 reference

12 December 2020

Increased glomerular alpha 1 (IV) collagen expression and deposition in long-term diabetic rats is prevented by chronic glycosaminoglycan treatment

1 reference

12 December 2020

New insights into the role of podocytes in proteinuria

1 reference

12 December 2020

Heparanase is involved in the pathogenesis of proteinuria as a result of glomerulonephritis

1 reference

12 December 2020

Increased expression of heparanase in puromycin aminonucleoside nephrosis

1 reference

12 December 2020

Abnormal glomerular permeability characteristics in diabetic nephropathy: implications for the therapeutic use of low-molecular weight heparin

1 reference

12 December 2020

Podocyte foot process effacement as a diagnostic tool in focal segmental glomerulosclerosis.

1 reference

12 December 2020

Increased expression of heparanase in overt diabetic nephropathy

1 reference

12 December 2020

CD2-associated protein haploinsufficiency is linked to glomerular disease susceptibility

1 reference

12 December 2020

In vivo antithrombotic synergy of oral heparin and arginine: endothelial thromboresistance without changes in coagulation parameters.

1 reference

12 December 2020

Signaling in regulation of podocyte phenotypes.

1 reference

12 December 2020

Nephrin and CD2AP associate with phosphoinositide 3-OH kinase and stimulate AKT-dependent signaling

1 reference

12 December 2020

Sulodexide suppresses inflammation in human endothelial cells and prevents glucose cytotoxicity

1 reference

12 December 2020

10.1007/S11596-009-0608-0

Identifiers

DOI

1 reference

16 November 2017

1 reference